These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12811706)

  • 1. A prospective double-blind study of nasal sumatriptan versus IV ketorolac in migraine.
    Meredith JT; Wait S; Brewer KL
    Am J Emerg Med; 2003 May; 21(3):173-5. PubMed ID: 12811706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Randomized Trial of Ketorolac vs. Sumatripan vs. Placebo Nasal Spray (KSPN) for Acute Migraine.
    Rao AS; Gelaye B; Kurth T; Dash PD; Nitchie H; Peterlin BL
    Headache; 2016 Feb; 56(2):331-40. PubMed ID: 26840902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous ketorolac vs intravenous prochlorperazine for the treatment of migraine headaches.
    Seim MB; March JA; Dunn KA
    Acad Emerg Med; 1998 Jun; 5(6):573-6. PubMed ID: 9660282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Faster Improvement in Migraine Pain Intensity and Migraine-Related Disability at Early Time Points with AVP-825 (Sumatriptan Nasal Powder Delivery System) versus Oral Sumatriptan: A Comparative Randomized Clinical Trial Across Multiple Attacks from the COMPASS Study.
    Lipton RB; McGinley JS; Shulman KJ; Wirth RJ; Buse DC
    Headache; 2017 Nov; 57(10):1570-1582. PubMed ID: 28880380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered
    Silberstein S; Winner PK; McAllister PJ; Tepper SJ; Halker R; Mahmoud RA; Siffert J
    Headache; 2017 Jun; 57(6):862-876. PubMed ID: 28497569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective, randomized trial of intravenous prochlorperazine versus subcutaneous sumatriptan in acute migraine therapy in the emergency department.
    Kostic MA; Gutierrez FJ; Rieg TS; Moore TS; Gendron RT
    Ann Emerg Med; 2010 Jul; 56(1):1-6. PubMed ID: 20045576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of sumatriptan and ketorolac trometamol in the human experimental model of headache.
    Ghanizada H; Al-Karagholi MA; Arngrim N; Mørch-Rasmussen M; Metcalf-Clausen M; Larsson HBW; Amin FM; Ashina M
    J Headache Pain; 2020 Feb; 21(1):19. PubMed ID: 32093617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks.
    Tepper SJ; Cady RK; Silberstein S; Messina J; Mahmoud RA; Djupesland PG; Shin P; Siffert J
    Headache; 2015 May; 55(5):621-35. PubMed ID: 25941016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of pediatric migraine headaches: a randomized, double-blind trial of prochlorperazine versus ketorolac.
    Brousseau DC; Duffy SJ; Anderson AC; Linakis JG
    Ann Emerg Med; 2004 Feb; 43(2):256-62. PubMed ID: 14747817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of subcutaneous sumatriptan in the treatment of recurrence of migraine headache.
    Cull RE; Price WH; Dunbar A
    J Neurol Neurosurg Psychiatry; 1997 May; 62(5):490-5. PubMed ID: 9153607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sumatriptan-naproxen for acute treatment of migraine: a randomized trial.
    Brandes JL; Kudrow D; Stark SR; O'Carroll CP; Adelman JU; O'Donnell FJ; Alexander WJ; Spruill SE; Barrett PS; Lener SE
    JAMA; 2007 Apr; 297(13):1443-54. PubMed ID: 17405970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors.
    Jakubowski M; Levy D; Goor-Aryeh I; Collins B; Bajwa Z; Burstein R
    Headache; 2005; 45(7):850-61. PubMed ID: 15985101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A trial of metoclopramide vs sumatriptan for the emergency department treatment of migraines.
    Friedman BW; Corbo J; Lipton RB; Bijur PE; Esses D; Solorzano C; Gallagher EJ
    Neurology; 2005 Feb; 64(3):463-8. PubMed ID: 15699376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study.
    Lipton RB; Munjal S; Brand-Schieber E; Rapoport AM
    Headache; 2018 May; 58(5):676-687. PubMed ID: 29878341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized, multicenter, parallel group study. The ASASUMAMIG Study Group.
    Diener HC
    Cephalalgia; 1999 Jul; 19(6):581-8; discussion 542. PubMed ID: 10448545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal sumatriptan for the acute treatment of migraine in children.
    Ueberall MA; Wenzel D
    Neurology; 1999 Apr; 52(7):1507-10. PubMed ID: 10227648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg) in adults with episodic migraine: a multicenter, randomized, double-blind, placebo-controlled study.
    Landy S; Munjal S; Brand-Schieber E; Rapoport AM
    J Headache Pain; 2018 Aug; 19(1):69. PubMed ID: 30112726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sumatriptan nasal spray 20mg: efficacy, tolerance and quality of life in migraine patients].
    Géraud G; Valette C
    Rev Neurol (Paris); 2000 Jul; 156(6-7):646-53. PubMed ID: 10891800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic migraine: a 3-month comparator study of naproxen sodium vs SumaRT/Nap.
    Cady R; Nett R; Dexter K; Freitag F; Beach ME; Manley HR
    Headache; 2014 Jan; 54(1):80-93. PubMed ID: 24020994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind placebo-controlled study assessing the efficacy and tolerability of 50 mg sumatriptan tablets in the acute treatment of migraine. Sumatriptan Tablets S2CM07 Study Group.
    Savani N; Brautaset NJ; Reunanen M; Szirmai I; Ashford EA; Hassani H; Saiers J
    Int J Clin Pract Suppl; 1999 Aug; 105():7-15. PubMed ID: 10692717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.